Education
About Us
Working with TipRanks
Follow Us
Precision BioSciences (DTIL)
NASDAQ:DTIL
Total Valuation
Precision BioSciences has a market cap or net worth of $88.69M. The enterprise value is $13.60M.
Market Cap$88.69M
Enterprise Value$13.60M
Share Statistics
Precision BioSciences has 13,256,751 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding13,256,751
Owned by Insiders3.44%
Owned by Institutions0.36%
Financial Efficiency
Precision BioSciences’s return on equity (ROE) is 0.13 and return on invested capital (ROIC) is -21.32%.
Return on Equity (ROE)0.13
Return on Assets (ROA)0.05
Return on Invested Capital (ROIC)-21.32%
Return on Capital Employed (ROCE)-0.22
Revenue Per Employee636.07K
Profits Per Employee66.36K
Employee Count108
Asset Turnover0.50
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Precision BioSciences is ―. Precision BioSciences’s PEG ratio is -0.03.
PE Ratio―
PS Ratio0.38
PB Ratio0.46
Price to Fair Value0.46
Price to FCF-0.44
Price to Operating Cash Flow-0.99
PEG Ratio-0.03
Income Statement
In the last 12 months, Precision BioSciences had revenue of 68.70M and earned 7.17M in profits. Earnings per share was 1.05.
Revenue68.70M
Gross Profit68.70M
Operating Income-26.16M
Pretax Income7.17M
Net Income7.17M
EBITDA13.53M
Earnings Per Share (EPS)1.05
Cash Flow
In the last 12 months, operating cash flow was -73.28M and capital expenditures -413.00K, giving a free cash flow of -73.69M billion.
Operating Cash Flow-73.28M
Free Cash Flow-73.69M
Free Cash Flow per Share-5.56
Dividends & Yields
Precision BioSciences pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.09
52-Week Price Change-26.73%
50-Day Moving Average5.87
200-Day Moving Average5.16
Relative Strength Index (RSI)43.32
Average Volume (3m)123.92K
Important Dates
Precision BioSciences upcoming earnings date is Mar 17, 2026, TBA (Confirmed).
Last Earnings DateNov 3, 2025
Next Earnings DateMar 17, 2026
Ex-Dividend Date―
Financial Position
Precision BioSciences as a current ratio of 6.34, with Debt / Equity ratio of 8.77%
Current Ratio6.34
Quick Ratio6.34
Debt to Market Cap0.91
Net Debt to EBITDA-4.13
Interest Coverage Ratio-14.68
Taxes
In the past 12 months, Precision BioSciences has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Precision BioSciences EV to EBITDA ratio is -2.20, with an EV/FCF ratio of 0.51.
EV to Sales-0.43
EV to EBITDA-2.20
EV to Free Cash Flow0.51
EV to Operating Cash Flow0.51
Balance Sheet
Precision BioSciences has $44.87M in cash and marketable securities with $29.13M in debt, giving a net cash position of $15.74M billion.
Cash & Marketable Securities$44.87M
Total Debt$29.13M
Net Cash$15.74M
Net Cash Per Share$1.19
Tangible Book Value Per Share$8.16
Margins
Gross margin is -1.58%, with operating margin of -38.08%, and net profit margin of 10.43%.
Gross Margin-1.58%
Operating Margin-38.08%
Pretax Margin10.43%
Net Profit Margin10.43%
EBITDA Margin19.69%
EBIT Margin13.03%
Analyst Forecast
The average price target for Precision BioSciences is $45.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$45.00
Price Target Upside632.90% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast-99.07%
EPS Growth Forecast-10347.56%